MX2016005998A - Solucion de atomoxetina. - Google Patents
Solucion de atomoxetina.Info
- Publication number
- MX2016005998A MX2016005998A MX2016005998A MX2016005998A MX2016005998A MX 2016005998 A MX2016005998 A MX 2016005998A MX 2016005998 A MX2016005998 A MX 2016005998A MX 2016005998 A MX2016005998 A MX 2016005998A MX 2016005998 A MX2016005998 A MX 2016005998A
- Authority
- MX
- Mexico
- Prior art keywords
- atomoxetine
- aqueous solution
- atomoxetine solution
- solution
- swallow
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona una composición farmacéutica de buen sabor, novedosa, en la forma de una solución acuosa de atomoxetina. La solución acuosa oral de esta invención reducirá significativamente el sabor potentemente amargo de la atomoxetina, y evitar un mayor problema de deglución en los pacientes jóvenes y de edad avanzada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361901577P | 2013-11-08 | 2013-11-08 | |
PCT/US2013/076435 WO2014204513A1 (en) | 2013-11-08 | 2013-12-19 | Atomoxetine solution |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016005998A true MX2016005998A (es) | 2016-07-18 |
MX365663B MX365663B (es) | 2019-06-10 |
Family
ID=49920679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005998A MX365663B (es) | 2013-11-08 | 2013-12-19 | Solucion de atomoxetina. |
Country Status (15)
Country | Link |
---|---|
US (1) | US9326935B2 (es) |
EP (1) | EP2838510B1 (es) |
JP (1) | JP5973073B2 (es) |
CN (1) | CN105705135A (es) |
CY (1) | CY1118100T1 (es) |
DK (1) | DK2838510T3 (es) |
ES (1) | ES2605495T3 (es) |
HU (1) | HUE032205T2 (es) |
IL (1) | IL244878A (es) |
MX (1) | MX365663B (es) |
PL (1) | PL2838510T3 (es) |
PT (1) | PT2838510T (es) |
SI (1) | SI2838510T1 (es) |
TW (1) | TWI583402B (es) |
WO (1) | WO2014204513A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105726473A (zh) * | 2016-03-31 | 2016-07-06 | 北京万全德众医药生物技术有限公司 | 托莫西汀或其可药用盐口服溶液及其制备方法 |
CN106727291B (zh) * | 2016-12-06 | 2020-02-11 | 山东达因海洋生物制药股份有限公司 | 一种盐酸托莫西汀口服溶液及其制备方法 |
US9855228B1 (en) * | 2016-12-14 | 2018-01-02 | Taho Pharmaceuticals Ltd. | Oral solution comprising atomoxetine hydrochloride and methods thereof |
CN111437247A (zh) * | 2019-01-17 | 2020-07-24 | 北京万全德众医药生物技术有限公司 | 一种托莫西汀口服液的制备方法 |
CN112438949A (zh) * | 2019-09-05 | 2021-03-05 | 北京兴源联合医药科技有限公司 | 一种含钙补充剂的盐酸托莫西汀口服液及其制备方法 |
CN112451476A (zh) * | 2019-09-09 | 2021-03-09 | 北京兴源联合医药科技有限公司 | 一种盐酸托莫西汀口服液及其制备方法 |
CN111956607A (zh) * | 2020-09-25 | 2020-11-20 | 健民药业集团股份有限公司 | 盐酸托莫西汀口服溶液及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT73982B (en) | 1980-11-14 | 1983-11-23 | Lilly Co Eli | Process for preparing 3-aryloxy-3-phenylpropylamines |
US5658590A (en) | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
SK12812002A3 (sk) * | 2000-03-07 | 2003-08-05 | Eli Lilly And Company | Spôsob liečenia psoriázy |
US20040033228A1 (en) * | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
US20050096311A1 (en) | 2003-10-30 | 2005-05-05 | Cns Response | Compositions and methods for treatment of nervous system disorders |
AU2004312059A1 (en) | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Atomoxetine formulations |
CN101155775A (zh) * | 2005-04-05 | 2008-04-02 | 特瓦药物精化学品股份有限公司 | 稳定的阿托莫西汀盐酸盐、其制备方法,以及其稳定性分析控制 |
US7569729B2 (en) * | 2005-04-05 | 2009-08-04 | Teva Pharmaceutical Fine Chemicals S.R.L. | Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
US20070134277A1 (en) * | 2005-12-09 | 2007-06-14 | Children's Medical Center Corporation | Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
WO2007103687A2 (en) | 2006-03-01 | 2007-09-13 | Tristrata, Inc. | Composition and method for topical treatment of tar-responsive dermatological disorders |
US20080031932A1 (en) | 2006-08-04 | 2008-02-07 | Watson Laboratories, Inc. | Transdermal atomoxetine formulations and associated methods |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US20080145318A1 (en) | 2006-12-13 | 2008-06-19 | Midha Kamal K | Atomoxetine formulations and associated methods |
CN102802617B (zh) * | 2009-12-18 | 2016-05-11 | 埃克索多斯生命科学有限合伙公司 | 用于稳定的液体药物制剂的方法和组合物 |
CA2793612C (en) | 2010-03-31 | 2019-06-25 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) formulations for treating autism |
CN103857440B (zh) | 2011-06-22 | 2018-09-25 | 维奥姆生物科学有限公司 | 基于缀合物的抗真菌和抗细菌前药 |
US9040082B2 (en) | 2011-06-24 | 2015-05-26 | K-Pax Pharmaceuticals, Inc. | Compositions and methods for treatment of chronic fatigue |
US20120128683A1 (en) | 2011-11-22 | 2012-05-24 | Shantha Totada R | Autism treatment |
-
2013
- 2013-12-19 HU HUE13818182A patent/HUE032205T2/en unknown
- 2013-12-19 PT PT138181821T patent/PT2838510T/pt unknown
- 2013-12-19 DK DK13818182.1T patent/DK2838510T3/en active
- 2013-12-19 EP EP13818182.1A patent/EP2838510B1/en not_active Revoked
- 2013-12-19 ES ES13818182.1T patent/ES2605495T3/es active Active
- 2013-12-19 CN CN201380080783.2A patent/CN105705135A/zh active Pending
- 2013-12-19 WO PCT/US2013/076435 patent/WO2014204513A1/en active Application Filing
- 2013-12-19 JP JP2015523309A patent/JP5973073B2/ja active Active
- 2013-12-19 MX MX2016005998A patent/MX365663B/es active IP Right Grant
- 2013-12-19 US US14/134,183 patent/US9326935B2/en active Active
- 2013-12-19 PL PL13818182T patent/PL2838510T3/pl unknown
- 2013-12-19 SI SI201330306A patent/SI2838510T1/sl unknown
-
2014
- 2014-01-10 TW TW103101018A patent/TWI583402B/zh active
-
2016
- 2016-04-04 IL IL244878A patent/IL244878A/en active IP Right Grant
- 2016-10-13 CY CY20161101032T patent/CY1118100T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014204513A1 (en) | 2014-12-24 |
CY1118100T1 (el) | 2017-06-28 |
IL244878A0 (en) | 2016-05-31 |
ES2605495T3 (es) | 2017-03-14 |
DK2838510T3 (en) | 2016-12-19 |
CN105705135A (zh) | 2016-06-22 |
US20150133562A1 (en) | 2015-05-14 |
TW201431567A (zh) | 2014-08-16 |
JP5973073B2 (ja) | 2016-08-23 |
PL2838510T3 (pl) | 2017-09-29 |
MX365663B (es) | 2019-06-10 |
EP2838510A1 (en) | 2015-02-25 |
IL244878A (en) | 2017-04-30 |
TWI583402B (zh) | 2017-05-21 |
JP2015522624A (ja) | 2015-08-06 |
SI2838510T1 (sl) | 2016-11-30 |
EP2838510B1 (en) | 2016-09-21 |
HUE032205T2 (en) | 2017-09-28 |
US9326935B2 (en) | 2016-05-03 |
PT2838510T (pt) | 2016-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX365663B (es) | Solucion de atomoxetina. | |
MX2021000550A (es) | Forma de dosis orales de liberacion sostenida de tofacitinib. | |
MX2015016676A (es) | Soluciones orales estables para api combinados. | |
PH12017502431A1 (en) | Pharmaceutical formulations comprising tenofovir and emtrictabine | |
PH12016500433A1 (en) | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine | |
IL273740A (en) | Oral pharmaceutical formulation containing bacteria | |
TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
PH12015500823A1 (en) | Modified release formulations for oprozomib | |
BR112014000347A2 (pt) | método para melhorar o aroma de um alimento, bebida, produto farmacêutico ou produto para o cuidado oral, e, alimento, bebida, produto farmacêutico ou produto para o cuidado oral | |
ES2524385R1 (es) | Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH | |
MX368117B (es) | Modulador de sabor y metodo para utilizar el mismo. | |
MX2016002560A (es) | Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir. | |
IN2014DN09240A (es) | ||
MX2014006201A (es) | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. | |
WO2016015798A9 (en) | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population | |
EP3065737A4 (en) | Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form | |
PH12014501822A1 (en) | Oral formulation comprising lansoprazole and the preparation method thereof | |
UA103542U (ru) | Настойка горька "таврийские мечты" | |
EP3141264A4 (en) | Pharmaceutical preparation for masked taste oral administration, containing clomipramine | |
UA88471U (ru) | Лекарственное средство в форме перорального раствора для лечения заболеваний органов пищеварения | |
MD4291C1 (ro) | Preparat medicamentos pentru tratamentul otitelor | |
MX2013003022A (es) | Composiciones farmaceuticas de montelukast y levocetirizina. | |
IN2014MU01179A (es) | ||
EA201101708A1 (ru) | Фармацевтическая композиция для лечения желудочных расстройств | |
EA200900174A8 (ru) | Фармацевтическая композиция для лечения желудочных расстройств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |